Trinity researchers have examined the effectiveness of a new blood test which could change the way Alzheimer’s disease is identified. The blood test (plasma p-tau217) detects the presence of amyloid plaques that build up in the brain of people with Alzheimer’s disease. In the Alzheimer’s brain, abnormal levels of this naturally occurring protein clump together to form plaques that disrupt normal cell function.
Medical Xpress – latest medical and health news stories
